GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium
Munich, Germany, August 5, 2019 – GNA Biosolutions GmbH, a molecular diagnostics company based in Germany, announced today that it has completed a $13.5M round of financing. The Series C financing round was joined by new investors including GreyBird Ventures, Occident, and Wachtumsfonds Bayern,... Read More →